Sigma Healthcare Limited (FRA:S5YA)
Germany · Delayed Price · Currency is EUR 1.770
-0.010 (-0.56%)
At close: Jan 30, 2026
Sigma Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 6,002 | 3,294 | 3,091 | 2,993 | 2,420 | |
Revenue Growth (YoY) | 82.18% | 6.59% | 3.27% | 23.67% | -3.48% |
Cost of Revenue | 4,562 | 2,251 | 2,173 | 1,921 | 1,752 |
Gross Profit | 1,440 | 1,043 | 917.7 | 1,072 | 668.3 |
Selling, General & Admin | 671.08 | 490.3 | 488.97 | 497.82 | 737.83 |
Operating Expenses | 671.08 | 490.3 | 488.97 | 497.82 | 737.83 |
Operating Income | 769.21 | 552.65 | 428.73 | 574.54 | -69.53 |
Interest Expense | -91.74 | -64.23 | -53.66 | -39.23 | -36.93 |
Interest & Investment Income | 50.48 | 44.94 | 18.42 | 3.85 | 29.65 |
Earnings From Equity Investments | 30.21 | 23.06 | 13.04 | 8.18 | 1.65 |
Other Non Operating Income (Expenses) | 31.95 | 17.7 | 22.83 | 2.65 | 6.47 |
EBT Excluding Unusual Items | 790.12 | 574.12 | 429.36 | 550 | -68.69 |
Merger & Restructuring Charges | -46.62 | - | - | - | - |
Other Unusual Items | - | - | - | - | 1.29 |
Pretax Income | 743.49 | 574.12 | 429.36 | 550 | -67.4 |
Income Tax Expense | 218.04 | 34.46 | 126.9 | 164.99 | 109.34 |
Earnings From Continuing Operations | 525.46 | 539.66 | 302.46 | 385.01 | -176.74 |
Minority Interest in Earnings | 4.46 | 1.36 | 1.87 | 0.92 | 0.76 |
Net Income | 529.91 | 541.01 | 304.33 | 385.93 | -175.98 |
Net Income to Common | 529.91 | 541.01 | 304.33 | 385.93 | -175.98 |
Net Income Growth | -2.05% | 77.77% | -21.14% | - | - |
Shares Outstanding (Basic) | 10,478 | 9,826 | 1,553 | 1,551 | 1,125 |
Shares Outstanding (Diluted) | 10,485 | 9,826 | 1,553 | 1,553 | 1,127 |
Shares Change (YoY) | 6.70% | 532.62% | - | 37.84% | 8.22% |
EPS (Basic) | 0.05 | 0.06 | 0.20 | 0.25 | -0.16 |
EPS (Diluted) | 0.05 | 0.06 | 0.20 | 0.25 | -0.16 |
EPS Growth | -8.05% | -71.93% | -21.24% | - | - |
Free Cash Flow | 546.27 | 240.34 | 432.4 | 271.28 | 304.98 |
Free Cash Flow Per Share | 0.05 | 0.02 | 0.28 | 0.17 | 0.27 |
Dividend Per Share | 0.013 | 0.010 | - | - | - |
Dividend Growth | 30.00% | - | - | - | - |
Gross Margin | 24.00% | 31.66% | 29.69% | 35.83% | 27.62% |
Operating Margin | 12.82% | 16.78% | 13.87% | 19.20% | -2.87% |
Profit Margin | 8.83% | 16.42% | 9.85% | 12.90% | -7.27% |
Free Cash Flow Margin | 9.10% | 7.29% | 13.99% | 9.06% | 12.60% |
EBITDA | 798 | 569.05 | 439.94 | 585.76 | -62.09 |
EBITDA Margin | 13.30% | 17.27% | 14.23% | 19.57% | -2.57% |
D&A For EBITDA | 28.79 | 16.4 | 11.21 | 11.22 | 7.44 |
EBIT | 769.21 | 552.65 | 428.73 | 574.54 | -69.53 |
EBIT Margin | 12.82% | 16.78% | 13.87% | 19.20% | -2.87% |
Effective Tax Rate | 29.33% | 6.00% | 29.55% | 30.00% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.